Press Releases
12 March 2008
Immtech Announces Update On Business Operations
22 February 2008
Immtech Focusing On New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine
19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008
13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor
11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results
06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008
28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1PM
26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
05 December 2007
Immtech And BioAlliance Sign Licensing Agreement For Pafuramidine
03 December 2007
Immtech To Present At The Bank Of Montreal Healthcare Conference
29 November 2007
Dr. Jubo Liu Joins Immtech China As Development Liaison For Clinical Trials
29 November 2007
Immtech Announces Posting Of Annual Shareholders Meeting Presentation
08 November 2007
Immtech Reports Fiscal Second Quarter 2008 Results
08 November 2007
Immtech Investor Conference Call Scheduled for November 9 at 3 PM
05 November 2007
Immtech Receives $5.1 Million to further African Sleeping Sickness Clinical Trials
05 November 2007
Immtech To Present At The Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
02 November 2007
Immtech Completes Malaria Prevention Trial
04 October 2007
Immtech Announces Interim Analysis In Phase III African Sleeping Sickness Trial
27 September 2007
Chinese SFDA Grants Immtech Fast Track Status
19 September 2007
US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness
10 September 2007
General Wesley Clark Joins Immtech As Consulting Strategic Advisor
28 August 2007
David Fleet Joins Immtech Board Of Directors
14 August 2007
Furamidine Found To Inhibit A Key Enzyme Involved In Cancer Cell DNA Repair Mechanisms
09 August 2007
Immtech Reports Fiscal First Quarter 2008 Results
08 August 2007
Immtech Retains CCG Investor Relations
20 June 2007
Immtech Completes Dosing Protocol of Malaria Prevention Trial
18 June 2007
US FDA Grants Orphan Drug Status to Immtech
13 June 2007
Immtech Reports Fiscal Year End 2007 Results
Download the free Adobe Acrobat PDF reader.
Terms of Use | Privacy Policy
© 2008 Immtech. All Rights Reserved
